Kiropraktisk Klinik Allerød ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 6.0% 10.5% 5.6%  
Credit score (0-100)  0 0 38 22 41  
Credit rating  N/A N/A BBB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 1,143 1,321 1,532  
EBITDA  0.0 0.0 -250 68.1 310  
EBIT  0.0 0.0 -427 -541 286  
Pre-tax profit (PTP)  0.0 0.0 -432.1 -547.6 285.3  
Net earnings  0.0 0.0 -396.6 -369.0 222.0  
Pre-tax profit without non-rec. items  0.0 0.0 -432 -548 285  

 
See the entire income statement

Balance sheet (kDKK) 
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 81.2 0.0 134  
Shareholders equity total  0.0 0.0 974 546 707  
Interest-bearing liabilities  0.0 0.0 2.2 32.9 0.5  
Balance sheet total (assets)  0.0 0.0 1,300 743 861  

Net Debt  0.0 0.0 -242 -307 -386  
 
See the entire balance sheet

Volume 
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 1,143 1,321 1,532  
Gross profit growth  0.0% 0.0% 0.0% 15.6% 16.0%  
Employees  0 0 3 3 3  
Employee growth %  0.0% 0.0% 0.0% 18.1% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 1,300 743 861  
Balance sheet change%  0.0% 0.0% 0.0% -42.8% 15.9%  
Added value  0.0 0.0 -249.5 -364.1 310.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 613 -1,300 111  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 -1.0 -2.0 1.0  

Profitability 
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% -37.4% -41.0% 18.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% -32.8% -53.0% 35.8%  
ROI %  0.0% 0.0% -37.8% -63.4% 43.8%  
ROE %  0.0% 0.0% -40.7% -48.6% 35.5%  

Solidity 
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  0.0% 0.0% 75.0% 73.4% 82.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 96.9% -450.6% -124.6%  
Gearing %  0.0% 0.0% 0.2% 6.0% 0.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 458.0% 35.3% 11.1%  

Liquidity 
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.0 0.0 2.2 2.6 3.9  
Current Ratio  0.0 0.0 2.3 2.7 4.0  
Cash and cash equivalent  0.0 0.0 243.9 339.8 386.7  

Capital use efficiency 
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 228.1 338.3 390.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -98 -121 103  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -98 23 103  
EBIT / employee  0 0 -168 -180 95  
Net earnings / employee  0 0 -156 -123 74